BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2012

Mar 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2012-03-01

Reporting Person: Babu Yarlagadda S (VP Drug Discovery)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-01	Common Stock	A	11200	—	Acquired	126606	Direct
2012-03-02	Common Stock	S	837	$4.78	Disposed	125769	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-01	Emp. Stock Option (Right to Buy)	$4.73	A	62000	Acquired	2022-03-01	Common Stock (62000)	Direct

Footnotes

F1: Restricted Stock Award-25% vest per year